Form 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 


 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 18, 2004

 

 


 

 

UGI CORPORATION

(Exact name of registrant as specified in its charter)

 

 

Pennsylvania   1-11071   23-2668356
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)

 

 

460 North Gulph Road

King of Prussia, Pennsylvania 19406

(Address of principal executive offices)      (Zip Code)

 

 

Registrant’s telephone number, including area code:    (610) 337-1000

 

 



Item 5. Other Events.

 

On March 18, 2004, UGI Corporation (the “Company”) entered into an Underwriting Agreement covering the issue and sale by the Company of 7,500,000 shares of its Common Stock (the “Shares”), a copy of which is attached to this Form 8-K and filed herewith under Item 7 as Exhibit 1.1. The Shares were registered by the Company under the Securities Act of 1933, as amended, pursuant to the Registration Statement on Form S-3/A (Reg. No. 333-112132).

 

 

Item 7. Financial Statements and Exhibits.

 

(c) Exhibits.

 

1.1    Underwriting Agreement, dated March 18, 2004, by and between the Company and Credit Suisse First Boston (Europe) Limited, as Representative of the Several Underwriters named in Schedule A thereto, relating to 7,500,000 shares of Common Stock.

 


SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

UGI CORPORATION

By:

 

/S/    MARGARET CALABRESE


    Name:    Margaret Calabrese
    Title:      Managing Counsel and Secretary

 

Dated:    March 19, 2004


EXHIBIT INDEX

 

 

1.1 Underwriting Agreement, dated March 18, 2004, by and between the Company and Credit Suisse First Boston (Europe) Limited, as Representative of the Several Underwriters named in Schedule A thereto, relating to 7,500,000 shares of Common Stock.